Candel Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

May 11, 2023

https://www.globenewswire.com/news-release/2023/05/11/2666694/0/en/Candel-Therapeutics-Reports-First-Quarter-2023-Financial-Results-and-Recent-Corporate-Highlights.html

NEEDHAM, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq:CADL), a clinical stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer, today reported financial results for the first quarter ended March 31, 2023, and provided a corporate update.

Read more at globenewswire.com

Related news for (CADL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.